Dr Chris Howard is a joint appointment research fellow at the Australian Institute for Bioengineering and Nanotechnology and the Centre for Advanced Imaging, UQ
He is a chief investigator within the ARC Industrial Transformation Training Centre for Biopharmaceutical Innovation and a leader on projects involving industrial partners including CSL and GE
Dr Howard is also an inventor of a patented platform technology for generating targeted nanomedicines using bispecific antibodies and a CI on an NHMRC project grant focused on this technology